BOTHELL,
Wash., March 4, 2024 /PRNewswire/ -- BioLife
Solutions, Inc. (NASDAQ: BLFS), a leading supplier of
class-defining bioproduction tools and services for the cell and
gene therapies ("CGT") and broader biopharma markets, today
announced that Roderick de Greef,
Chief Executive Officer, and Troy Wichterman, Chief Financial
Officer, will present and meet with current and prospective
investors at the following March Investor Conferences.
- TD Cowen 44th Annual Healthcare
Conference (Boston, MA):
March 5-6th
- 1:1 Meeting on both days
- Fireside chat – Wednesday March
6th 9:15-9:45am
ET
- Key Banc Virtual Conference: March
20th
- Fireside chat – 11:15 am-12:00 pm
PT
About BioLife Solutions
BioLife Solutions is a leading supplier of class-defining
bioproduction tools and services for the cell and gene therapy
(CGT) and broader biopharma markets. Our expertise facilitates the
commercialization of new therapies by supplying solutions that
maintain the health and function of biologic materials during
collection, development, storage, and distribution. For more
information, please visit www.biolifesolutions.com or follow
BioLife on LinkedIn and X.
Media & Investor Relations
At the Company
Troy Wichterman
Chief Financial Officer
(425) 402-1400
twichterman@biolifesolutions.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/biolife-solutions-to-present-at-td-cowen-and-key-bank-investor-conferences-302076096.html
SOURCE BioLife Solutions, Inc.